PL1704141T3 - Nitrooksypochodne prostaglandyn - Google Patents

Nitrooksypochodne prostaglandyn

Info

Publication number
PL1704141T3
PL1704141T3 PL04804405T PL04804405T PL1704141T3 PL 1704141 T3 PL1704141 T3 PL 1704141T3 PL 04804405 T PL04804405 T PL 04804405T PL 04804405 T PL04804405 T PL 04804405T PL 1704141 T3 PL1704141 T3 PL 1704141T3
Authority
PL
Poland
Prior art keywords
nitrooxyderivatives
prostaglandin
prostaglandin nitrooxyderivatives
Prior art date
Application number
PL04804405T
Other languages
English (en)
Inventor
Ennio Ongini
Francesca Benedini
Valerio Chiroli
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34778199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1704141(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of PL1704141T3 publication Critical patent/PL1704141T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PL04804405T 2004-01-05 2004-12-27 Nitrooksypochodne prostaglandyn PL1704141T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04100001 2004-01-05
PCT/EP2004/014820 WO2005068421A1 (en) 2004-01-05 2004-12-27 Prostaglandin nitrooxyderivatives
EP04804405.1A EP1704141B1 (en) 2004-01-05 2004-12-27 Prostaglandin nitrooxyderivatives

Publications (1)

Publication Number Publication Date
PL1704141T3 true PL1704141T3 (pl) 2016-08-31

Family

ID=34778199

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04804405T PL1704141T3 (pl) 2004-01-05 2004-12-27 Nitrooksypochodne prostaglandyn

Country Status (39)

Country Link
US (5) US7273946B2 (pl)
EP (3) EP1704141B1 (pl)
JP (1) JP3984283B2 (pl)
KR (2) KR100850133B1 (pl)
CN (1) CN100469765C (pl)
AP (1) AP2006003638A0 (pl)
AR (2) AR047081A1 (pl)
AU (1) AU2004313688B2 (pl)
BR (1) BRPI0418245B8 (pl)
CA (1) CA2551409C (pl)
CR (2) CR8498A (pl)
CY (1) CY1117417T1 (pl)
DK (1) DK1704141T3 (pl)
EA (1) EA010595B1 (pl)
EC (1) ECSP066684A (pl)
ES (2) ES2566800T3 (pl)
GE (1) GEP20094780B (pl)
GT (1) GT200500293A (pl)
HR (1) HRP20160500T1 (pl)
HU (1) HUE027357T2 (pl)
IL (1) IL176416A (pl)
MA (1) MA28284A1 (pl)
ME (1) ME02433B (pl)
MX (1) MXPA06007678A (pl)
MY (1) MY147181A (pl)
NO (2) NO337217B1 (pl)
NZ (1) NZ548271A (pl)
OA (1) OA13356A (pl)
PA (1) PA8620901A1 (pl)
PE (1) PE20051052A1 (pl)
PL (1) PL1704141T3 (pl)
RS (1) RS54717B1 (pl)
SI (1) SI1704141T1 (pl)
TN (1) TNSN06210A1 (pl)
TW (1) TWI337994B (pl)
UA (1) UA84726C2 (pl)
UY (1) UY28709A1 (pl)
WO (1) WO2005068421A1 (pl)
ZA (1) ZA200605354B (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1704141B1 (en) * 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives
JP2009500315A (ja) * 2005-06-29 2009-01-08 ファイザー・インク フルオロプロスタグランジンのニトロ誘導体
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
CA2647859C (en) * 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
DE102006052755A1 (de) * 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
WO2008071421A1 (en) * 2006-12-15 2008-06-19 Nicox S.A. Nitrate esters of carbonic anhydrase inhibitors
CA2671137A1 (en) 2006-12-15 2008-06-26 Nicox S.A. Carbonic anhydrase inhibitors derivatives
JP2010529101A (ja) 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用
WO2009035565A1 (en) * 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Prostaglandin analogues for implant devices and methods
US7632868B2 (en) * 2007-10-31 2009-12-15 Meta Cosmetics, Llc Prostaglandin analog compositions to treat epithelial-related conditions
AR076731A1 (es) * 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
US7807716B2 (en) * 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
EP2383263B1 (en) 2008-12-30 2014-04-16 Industry-academic Cooperation Foundation, Chosun University Novel thiazolidinedione derivative and use thereof
CN102498088A (zh) * 2009-09-15 2012-06-13 帝斯曼知识产权资产管理有限公司 硝基氧基酯及其制备和用途
CN101885684B (zh) * 2010-07-01 2013-10-30 南京中医药大学 带有一氧化氮供体的芳香酸前体药物及其制备方法和其应用
US20130053794A1 (en) 2011-08-29 2013-02-28 Suzanne Cadden Sustained release delivery of active agents to treat glaucoma and ocular hypertension
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
WO2013164671A1 (en) 2012-05-03 2013-11-07 Qlt Inc. Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP2911656B1 (en) * 2012-10-23 2020-12-02 Nicox SA Quinone based nitric oxide donating compounds for ophthalmic use
JP6306148B2 (ja) * 2013-04-18 2018-04-04 ニコックス サイエンス アイルランド 点眼用のキノン系一酸化窒素供与性化合物
WO2015106068A1 (en) 2014-01-10 2015-07-16 Manistee Partners Llc Treatment of migraines
BR112017007095B1 (pt) * 2014-10-15 2023-03-14 Alcon Inc Conjugados e derivados de prostaglandina, seu uso, e composição farmacêutica oftálmica
WO2016155906A1 (en) * 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
HU231175B1 (hu) * 2015-12-04 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Tetszőleges, előre meghatározott minőségű Latanoprostene bunod előállítása gravitációs kromatográfiával
JP7055802B2 (ja) * 2016-11-08 2022-04-18 ボシュ・アンド・ロム・インコーポレイテッド 正常眼圧緑内障を処置するための一酸化窒素放出プロスタグランジン誘導体
KR102069205B1 (ko) * 2017-08-09 2020-01-22 연성정밀화학(주) 라타노프로스틴 부노드의 제조 방법 및 그를 위한 중간체
RU2718744C2 (ru) 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
CN109988089B (zh) * 2018-05-29 2022-04-26 上海凡秦医药科技有限公司 一种前列腺素化合物、制备方法及其用途
CN108892624B (zh) * 2018-06-20 2020-12-15 重庆威鹏药业有限公司 沙库巴曲硝基氧衍生物及其制备方法和应用
HUE064405T2 (hu) * 2019-08-05 2024-03-28 Nicox Sa Eljárás nitrogén-oxid donor prosztaglandin analóg elõállítására
US11332433B2 (en) 2020-07-24 2022-05-17 Chirogate International Inc. Process for the preparation of latanoprostene bunod and intermediate thereof and compositions comprising the same
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
CN116444377A (zh) * 2022-01-07 2023-07-18 广州楷石医药有限公司 一种氧化氮供体型曲前列尼尔类衍生物及其药物组合物和用途
CA3195291A1 (en) * 2022-04-13 2023-10-13 Caravel Therapeutics, Inc. Preservative-free ophthalmic pharmaceutical emulsion and its application

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922293A (en) 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
DE68929435T2 (de) 1988-09-06 2003-07-17 Pharmacia Ab, Stockholm Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
ES2105333T3 (es) 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292377B1 (it) * 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US20030018079A1 (en) 2000-11-13 2003-01-23 Richardson Helene Treatment
US7816399B2 (en) * 2001-04-19 2010-10-19 Teika Pharmaceutical Co., Ltd. Medicines and medicinal kits
EP1704141B1 (en) * 2004-01-05 2016-02-24 Nicox S.A. Prostaglandin nitrooxyderivatives

Also Published As

Publication number Publication date
ES2566800T3 (es) 2016-04-15
NO20063567L (no) 2006-09-07
HK1096084A1 (zh) 2007-05-25
EP3643702A1 (en) 2020-04-29
US20090030076A1 (en) 2009-01-29
EA010595B1 (ru) 2008-10-30
CA2551409C (en) 2011-02-22
NO339685B1 (no) 2017-01-23
US20100130507A1 (en) 2010-05-27
EP1704141B1 (en) 2016-02-24
DK1704141T3 (en) 2016-05-02
ZA200605354B (en) 2009-09-30
US20050272743A1 (en) 2005-12-08
AU2004313688B2 (en) 2010-08-05
BRPI0418245B1 (pt) 2017-05-30
EA200601099A1 (ru) 2006-10-27
AP2006003638A0 (en) 2006-06-30
NZ548271A (en) 2010-01-29
HRP20160500T1 (hr) 2016-06-03
PA8620901A1 (es) 2005-08-30
GEP20094780B (en) 2009-09-25
UY28709A1 (es) 2005-08-31
US20080058392A1 (en) 2008-03-06
AU2004313688A1 (en) 2005-07-28
CY1117417T1 (el) 2017-04-26
AR047081A1 (es) 2006-01-04
SI1704141T1 (sl) 2016-04-29
US7449469B2 (en) 2008-11-11
KR100850133B1 (ko) 2008-08-04
KR20080007415A (ko) 2008-01-18
CR8498A (es) 2006-11-15
BRPI0418245A (pt) 2007-04-17
US20110136904A1 (en) 2011-06-09
WO2005068421A8 (en) 2006-02-09
TNSN06210A1 (fr) 2007-12-03
US7910767B2 (en) 2011-03-22
US8058467B2 (en) 2011-11-15
ES2767136T3 (es) 2020-06-16
TWI337994B (en) 2011-03-01
TW200526567A (en) 2005-08-16
GT200500293A (es) 2007-07-06
RS54717B1 (sr) 2016-08-31
JP3984283B2 (ja) 2007-10-03
EP3002277B1 (en) 2019-11-06
CR20110131A (es) 2011-03-30
MA28284A1 (fr) 2006-11-01
US7629345B2 (en) 2009-12-08
WO2005068421A1 (en) 2005-07-28
NO20151341A1 (no) 2006-09-07
AR098931A2 (es) 2016-06-22
EP3002277A1 (en) 2016-04-06
US7273946B2 (en) 2007-09-25
PE20051052A1 (es) 2005-12-17
MY147181A (en) 2012-11-14
CA2551409A1 (en) 2005-07-28
BRPI0418245B8 (pt) 2021-05-25
CN100469765C (zh) 2009-03-18
IL176416A (en) 2013-05-30
OA13356A (en) 2007-04-13
EP1704141A1 (en) 2006-09-27
HUE027357T2 (en) 2016-09-28
ECSP066684A (es) 2006-10-25
ME02433B (me) 2016-09-20
MXPA06007678A (es) 2006-09-01
NO337217B1 (no) 2016-02-15
KR100854838B1 (ko) 2008-08-29
JP2007518716A (ja) 2007-07-12
CN1906159A (zh) 2007-01-31
IL176416A0 (en) 2006-10-05
KR20060113753A (ko) 2006-11-02
UA84726C2 (ru) 2008-11-25

Similar Documents

Publication Publication Date Title
IL176416A0 (en) Prostaglandin nitrooxyderivatives
ZA200700357B (en) Tetrapetide analogs
ZA200609595B (en) Novel CIS-Imidazolines
IL179730A0 (en) Novel cis-imidazolines
TWI372750B (en) Novel hydroxy-6-heteroarylphenanthridines
EP1732560A4 (en) SUBSTITUTED CINNOLINE-4-YLAMINE
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
GB0401269D0 (en) Compounds
GB0405101D0 (en) Compounds
SG138605A1 (en) Prostaglandin reductase
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
ZA200610303B (en) Novel cis-imidazolines
GB0403593D0 (en) Compounds
GB0408865D0 (en) Novel benzoxazocines
ZA200606635B (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines
GB0403595D0 (en) Compounds
GB0416224D0 (en) Easy rockeries
GB0414361D0 (en) Privatise easy
GB0505847D0 (en) Novel benzoxazocines
GB0408863D0 (en) Novel benzoxazocines
GB0408862D0 (en) Novel benzoxazocines
ZA200608482B (en) Novel tetrahydropyridothiophenes
GB0404081D0 (en) Compounds
GB0401656D0 (en) Compounds
GB0404104D0 (en) Compounds